adjustment took place but did not mention whether these variables were from baseline or over the trail period (i.e. antihypertensive). Results -Please mention again the number of participants ascertained with time of CV event (page 9). -Table 1 : Merge the column where same information for 1998 and 2007 (i.e gender, race) . Correct the unit for diuretics. Please clarify what is meant by smoking -active or ever? - Table 2 : Suggest provide the number of participants with 4 and 8 visits - Table 3 & 4: suggest conducting the analyses among the same patients for different readings (8 to 20), if not done for this table. Mention the number of patients.
-It is not clear why 6 reading has been chosen as minimum reading. Either in the method or result section more detail information need to be provided. Also it is not clear whether the minimum number of BP reading predict CV outcome or not (provide odds ratio). Discussion -The discussion section needs to be rewritten to compare the findings with current available information from other literature (i.e. meta-analysis Diaz KM et al Hypertension. 2014; 64)
REVIEWER
Chenkai WU Duke Kunshan University, China REVIEW RETURNED 17-Aug-2018
GENERAL COMMENTS Summary
This study examined the reproducibility of long-term visit-to-visit blood pressure variability (BPV) and the minimum number of BP measurements needed to estimate long-term visit-to-visit BPV for predicting 10-year CV risk. My biggest concern is about assessing BPV using coefficient of variation (CV). CV or SD of BP conflates systematic changes (e.g., linear change) and pure variability, which can be measured using root-mean-square-error (RMSE). Please check the following three papers for how to calculate RMSE to measure BPV:
• Suchy-Dicey, A. M., Wallace, E. R., Elkind, M. S., Aguilar, M., Gottesman, R. F., Rice, K., ... & Longstreth Jr, W. T. (2013) . Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. American journal of hypertension, 26(10), 1210-1217.
• Gao, S., Hendrie, H. C., Wang, C., Stump, T. E., Stewart, J. C., Kesterson, J., ... & Callahan, C. M. (2014) . Redefined Blood Pressure Variability Measure and Its Association With Mortality in Elderly Primary Care Patients Novelty and Significance. Hypertension, 64(1), 45-52.
• Wu, C., Shlipak, M. G., Stawski, R. S., Peralta, C. A., Psaty, B. M., Harris, T. B., ... & Odden, M. C. (2017) . Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes among older adults: the health, aging, and body composition study. American journal of hypertension, 30(2), 151-158. Major comments:
Introduction: the statement, "However, these data were derived from randomized controlled trials which used a systematic and standardized protocol in BP measurement by the investigators." is not entirely correct, as BPV has been examined as a CVD risk factor in numerous cohort studies. I listed a few examples below:
• Gao, S., Hendrie, H. C., Wang, C., Stump, T. E., Stewart, J. Methods: I was wondering how the authors dealt with BP lowering medication use, which has a huge effect on the level of BP?
Methods: I think the authors should take the multiple comparison issue into consideration when examining the number of BP needed to calculated BPV that is predictive of CVD events.
Methods: I assume that the number of participants with 20 BP measurements is different from the number of people with 40 measurements (smaller sample size due to the occurrence of CVD events over the study period). This is however not mentioned in the methods section nor reflected in Table 3 .
Results: the ICC for SD of SBP is quite low; this needs more careful interpretation and comments.
Minor comments:
Introduction: The sentence "However there is still a lack of studies on the number of BP measurements needed to calculate visit-tovisit BPV." is redundant.
REVIEWER

Sebastiano Sciarretta
Sapienza University of Rome, Italy REVIEW RETURNED 14-Sep-2018
GENERAL COMMENTS
This study analyzed the required minimum number of blood pressure (BP) measurements to calculate visit-to-visit variability in a reliable manner in a large Asian population without baseline cardiovascular diseases. The authors found a correlation between the number of BP measurements and the prognostic value of the calculated BP variability. Remarkably, a minimum of 6 BP measurements was sufficient to appropriately estimate BP variability.
In general, this study is interesting and potentially relevant. The paper is clear and well written. There are few issues that should be addressed in order to further increase the significance of their work. In details:
1) The authors should perform ROC comparison analyses to compare the prognostic values of BP variability calculated with different numbers of measurements, with respect to the reference value.
2) Inclusion and exclusion criteria should be clearly specified. Criteria to exclude baseline CV diseases should also be explained.
3) The impact of pharmacological therapy should be taken into account when statistical analyses are performed. We corrected the subheading "primary and secondary outcome" to "Outcome measures" as suggested
VERSION 1 -AUTHOR RESPONSE
We changed the "Abstract -outcome measures" paragraph (page 2) to read as:
"The effect of the number of BP measurement for calculation of long-term visit-to-visit BPV in predicting 10-year cardiovascular risk" -Result section did not provide the answer for the objective (minimum BP records needed to predict CV outcome)
Authors' respond:
We added in a sentence under "Abstract, Results" (page 2) to read as:
"Hence, a minimum of six BP measurements is needed for reliably estimating intra-individual BPV for CV outcome prediction."
Methods -Need to provide clear definition of CV outcome -Which CV events are considered? Whether these events are counted on first occurrence for a patient or multiple events were counted for a patient. If multiple, than the author need to redo the analysis based on the number of patients had outcome.
The definition of CV outcomes were stated in the subheading of "Methods -Cardiovascular Disease Outcome" (page 6). We added in the clarification of CV outcomes as below:
"Cardiovascular disease (CVD) events occurring any time from year 1998 to 2007 were captured from the patients' medical records. These included fatal myocardial infarction, non-fatal myocardial infarction and angina, fatal and non-fatal stroke, heart failure and peripheral vascular disease. The CV outcome is counted for the first occurrence only for a patient."
-Need to mention how many BP readings available for a person (median, range, IQR)
We analyzed the median number of BP readings available for each person. We now added the statement under "Methods-Statistical analysis" paragraph 4 (page 8) as below:
"The median BP measurements for each patient was 32 readings with interquartile range, IQR 27-36 readings, range 7-40 readings."
-The authors need to justify why they choose '4 vs 4' and '8 vs 8' BP readings for checking reproducibility Authors' respond:
As patients were usually followed up at the clinic once every 3 months , and had blood pressure measured every 3-monthly, giving 4 readings per year, we hence tested the reproducibility using 4 and 8 readings based on estimated duration of 1 year (4 readings) vs 2 years (8 readings) of BP measurement.
We added in the reason under "Method-statistical analysis", paragraph 2 (page 7) as below:
"BP measurements were done every 3-monthly (4 readings per year) during their clinic follow-up. Hence, analyzing the reproducibility using 4 and 8 BP readings was based on the estimated BP measurement for 1 year (4 readings) vs 2 years (8 readings) duration."
-It was also not sure why 20 readings have been chosen as reference to assess predicting capacity.
Authors' respond:
It is because the SD of SBP calculated from 20 readings onwards is significantly associated with risk of CV event. And hence BPV calculated with 20 readings is used as a reference point to compare the concordance with the SD of SBP calculated with fewer readings to find out a reliable number of readings for intra-individual BPV.
We added the explanation under "Methods-Statistical analysis" paragraph 4 (page 8) as below:
"To determine the number of BP measurements needed for the calculation of reliable BPV, we used the SD calculated from 20 measurements as a reference for comparison with SD calculated with reduced number of visits because SD of SBP calculated from more than 20 readings onwards was significantly associated with risk of CV event."
-Analysis section need more detail information. For adjusted logistic regression (i.e. Table 3) analyses -more detail information needed. The author mentioned some variables for which adjustment took place but did not mention whether these variables were from baseline or over the trail period (i.e. antihypertensive).
For the adjusted logistic regression, the adjusted variables were taken from over the 10-year study period.
We added the information into "Methods-Statistical analysis", paragraph 3 (page 8) as below:
"Multiple logistic regression was used to examine the association of SD of SBP and risk of CVD events. The odd ratio (OR) was calculated for each cumulative number of visits, adjusted for age, sex, race, presence of diabetes mellitus, use of antihypertensive medications, HbA1c, total cholesterol, LDL cholesterol, smoking, chronic kidney disease and mean systolic blood pressure. The variables used for the multiple logistic regression model were based on the data collected over the 10-year study period."
Results -Please mention again the number of participants ascertained with time of CV event (page 9).
We amended the sentence under "Results" first paragraph (page 9) as below:
"Amongst those in whom we had ascertained the time of CV events (n=89, 49.4%), there was no difference in the SD of SBP before and after the onset of CV event (13.8mmHg vs 13.4mmHg, p=0.60)." - The definition of smoking has been stated in "Methods-data collection" section (page 5). We explained in more details regarding the smoking status.
Smoking status was defined as current smokers and non-smokers (including ex-smokers) Smoking is defined as those patients who were still actively smoking while non-smokers were those who never smoked or were ex-smokers.
- Table 2 : Suggest provide the number of participants with 4 and 8 visits Authors' respond:
Amendment was done on Table 2 . Number of patients with 4 readings was 1403 while with 8 readings was 1399.
- We have now included number of patients in Table 3 and 4 for each number of BP readings. 11.5 ± 6.9 1.9 0.34 0.45 (0.39-0.51) <0.001 1403 Delta, Difference in SD of SBP compared to SD of SBP calculated from 20 BP measurements; r, Pearson's coefficient -It is not clear why 6 reading has been chosen as minimum reading. Either in the method or result section more detail information need to be provided. Also it is not clear whether the minimum number of BP reading predict CV outcome or not (provide odds ratio).
As shown in Table 4 , compared to 20 BP measurements, the ICC values increase over the number of BP measurements, starting from ICC value of 0.45 with 3 BP measurements to ICC value of 0.97 with 16 BP measurements. According to a guideline of selecting and reporting ICC for reliability research by Koo et al (2016) , the ICC values between 0.75 and 0.90 indicate good reliability. In our study, the ICC of 0.75 is reached with 6 BP measurements with 95% CI 0.71-0.77.
We now included the explanation under "Methods, statistical analysis", paragraph4 ( We have now added comparison of other literature under "Discussion, paragraph 1" (page 13) as below:
"Studies have stressed that the number of BP measurements is very important in the calculation of visitto-visit BPV for prediction of outcome risk. (9, 27) However, comparison of BPV between studies was difficult due to variations in the number of measurements used for calculation of the BPV. Two systematic reviews and meta-analysis studies on visit-to-visit BPV and CVD risk have pointed out the need for standardization of the number of visits when defining visit-to-visit BPV. (17, 18) Our study added to the evidence showing the effect of the number of BP measurements in calculating visit-to-visit BPV. Our study has shown that SD of SBP increased with more number of BP measurements included for the calculation of BPV………."
We have added a new paragraph under Discussion, paragraph 4" (page 15) to address the comparison of other literature and address the comment of Reviewer 2 (1 st comment) in subsequent section. Reviewer: 2 Reviewer Name: Chenkai WU Institution and Country: Duke Kunshan University, China Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below Summary This study examined the reproducibility of long-term visit-to-visit blood pressure variability (BPV) and the minimum number of BP measurements needed to estimate long-term visit-to-visit BPV for predicting 10-year CV risk. My biggest concern is about assessing BPV using coefficient of variation (CV). CV or SD of BP conflates systematic changes (e.g., linear change) and pure variability, which can be measured using root-mean-square-error (RMSE). Please check the following three papers for how to calculate RMSE to measure BPV:
• Suchy-Dicey, A. M., Wallace, E. R., Elkind, M. S., Aguilar, M., Gottesman, R. F., Rice, K., ...&Longstreth Jr, W. T. (2013). Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. American journal of hypertension, 26(10), 1210-1217.
• Gao, S., Hendrie, H. C., Wang, C., Stump, T. E., Stewart, J. • Wu, C., Shlipak, M. G., Stawski, R. S., Peralta, C. A., Psaty, B. M., Harris, T. B., ... &Odden, M. C. (2017). Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes among older adults: the health, aging, and body composition study. American journal of hypertension, 30(2), 151-158.
We are aware of the assessment of visit-to-visit BPV with residual SD which is calculated using rootmean-square error (RMSE) from the regression. This measurement is less influenced by the BP level change over time compared to SD. However, RMSE is based on the assumption that a patient's BP increases "linearity" over time (Yano et al, 2017) . Currently, there is no consensus on a gold-standard approach to measure visit-to-visit BP variability. SD of SBP was more commonly being reported in visit-to-visit BPV studies compared to the residual SD using RMSE. As shown in a systematic review by Diaz et al 2015, among 37 studies on visit-to-visit BPV and CVD, 22 studies reported using SD while only two studies used RMSE. Another systematic review on visit-to-visit BPV and CVD by Wang et al 2017 excluded those studies reporting RMSE in their systematic review. In Diaz at al review, wide range of number of BP measurements were used to calculate SD of SBP, ranging from 3 to 256 visits in different cohorts. Hence, SD of SBP was used in our study to calculate BPV with the aim to draw the attention of researchers and clinicians on the effect of number of BP measurements in calculating BPV and what is the minimum reliable BP measurement needed. Furthermore, for the implementation of visit-to-visit BPV in clinical practice, SD is easier and more practical for the clinicians to obtain. (Yano et al 2017) .
We added the above explanation under "Discussion" paragraph 4 (page 15-16) as below:
"Studies have assessed the long-term visit-to-visit blood pressure variability using root-mean-square error (RMSE) which calculates the SD of the residuals from the linear regression of the SBP measurements. (27) (28) (29) This residual SD is different from the conventional BPV metrics such as SD, CV and ARV because residual SD is less influenced by the BP level change over time compared to SD, however this is based on the assumption that a patient's BP increases in a linear pattern over time. (30) Up to date, there was no consensus on a gold standard approach to measure and report the visit-to-visit BPV. For this present study, SD of SBP was used as the main BPV metric for analysis because SD of SBP was more commonly reported in studies examining association of visitto-visit BPV and CVD compared to RMSE. (17, 18) As shown in a systematic review by Diaz et al 2015, among 37 studies on visit-to-visit BPV and CVD, 22 studies reported using SD while only two studies reported using RMSE. (17) 
Major comments:
• Suchy-Dicey, A. M., Wallace, E. R., Elkind, M. S., Aguilar, M., Gottesman, R. F., Rice, K., ...&Longstreth Jr, W. T. (2013) . Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. American journal of hypertension, 26(10), 1210-1217.
• Gao, S., Hendrie, H. C., Wang, C., Stump, T. E., Stewart, J. C., Kesterson, J., ...& Callahan, C. M. (2014) . Redefined Blood Pressure Variability Measure and Its Association With Mortality in Elderly Primary Care Patients Novelty and Significance. Hypertension, 64(1), 45-52.
• Wu, C., Shlipak, M. G., Stawski, R. S., Peralta, C. A., Psaty, B. M., Harris, T. B., ... &Odden, M. C. (2017). Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes among older adults: the health, aging, and body composition study. American journal of hypertension, 30(2), 151-158.
Authors' respond:
Thank you for the references. We deleted the above statement under "Introduction".
Methods: is there any particular reasons to test reproducibility based on 4 and 8 BP measurements? Authors' respond: As patients were usually followed up at the clinic once every 3 months , and had blood pressure measured every 3-monthly, giving 4 readings per year, we hence tested the reproducibility using 4 and 8 readings based on estimated duration of 1 year (4 readings) vs 2 years (8 readings) of BP measurement.
Methods: Variability of DBP has been documented as CVD risk factor, why not looking at SBP only?
In our present study, both mean DBP and SD of DBP were not significantly associated with cardiovascular event (mean DBP; OR 1.0 95%CI 0.94-1.0, p=0.16; SD of DBP OR 1.14 95% CI 1.0-1.31, p=0.06). Hence DBP was not included in the analysis of the study which mainly focus of effect of number of BP measurements in BPV. According to a systematic review and meta-analysis by Diaz et al and Wang et al showed that visit-to-visit variability (VVV) of SBP is more often investigated and reported than DBP. Levitan et al which examined the effect number and timing of visits in VVV of BP also focused on intra-individual SD of SBP only.
We added the explanation under "Methods -Statistical Analysis" paragraph 1 (page 7) as below:
"BPV of diastolic blood pressure (DBP) was not included in this present analysis because mean DBP and SD of DBP were not significantly associated with CV outcome in this present study (mean DBP; OR 1.0 95%CI 0.94-1.0, p=0.16; SD of DBP OR 1.14 95% CI 1.0-1.31, p=0.06).Furthermore, visit-tovisit variability of SBP is more often investigated than DBP. (17,18) Thus only SD of SBP was analyzed and reported in this study" We are aware of that BP lowering medication use has a huge effect on the level of BP, thus we have included the use of antihypertensive medication inside the multiple logistic regression model in calculating the odd ratio of CV event.
We mentioned this in our limitation section under "Discussion", Paragraph 5 (page 16) as below:-"We have included the use of antihypertensive medications as one of the variable in the multiple logistic regression for analysis of the odd ratio of CV event"
Multiple comparison analysis was performed using a false recovery rate of 5%. (McDonald, J.H. 2014) Based on this, the largest p-value that was less than the Benjamini-Hochberg (BH) value was with 20 measurements. Methods: I assume that the number of participants with 20 BP measurements is different from the number of people with 40 measurements (smaller sample size due to the occurrence of CVD events over the study period). This is however not mentioned in the methods section nor reflected in Table  3. Author's respond:
We added in the number of participants for each number of BP readings in Table 3 . We added the explanation under "Methods-Statistical analysis" paragraph 3 (page 7) as below:
"As the number of BP measurement increased, the number of patients decreased. This was because patients who had CV event or died would have lesser BP readings. Also, there were patients who defaulted clinic visits or had less than 4 visits per year" Results: the ICC for SD of SBP is quite low; this needs more careful interpretation and comments.
Author's respond:
We highlighted this point under "Results-Reproducibility of visit-to-visit SBP in clinical practice" (page 10) as below:-"Mean SBP has good reproducibility with ICC 0.79 for first 4 vs second 4 measurements and 0.82 for first 8 vs second 8 measurements. BPV metrics have much lower reproducibility compared to mean SBP.Among the visit-to-visit BPV metrics, the ICC values for SD of SBP were higher (0.25 for comparing the first 4 and the second 4 measurements; 0.38 for comparing first 8 and second 8 readings, p<0.001) compared to CV and ARV of SBP."
We discussed this point under "Discussions" paragraph 2 (page 14) as below:-"Despite both Munter et al and our study showed significant results in the reproducibility of SD of SBP, we have to be aware of the low ICC for SD of SBP compared to mean SBP. This is consistent with a study which showed that the mean SBP still remains to be more superior to BPV in prognosticating CV events. (Schutte et al 2012) 
